Device/Diagnostics Quarterly Deal Statistics, Q1 2012
A look at financing, M&A, and alliance activity January–March 2012
Medical device companies raised $1.1 billion, a 40% increase over Q4 2011’s $800 million. Two billion-dollar deals in the resuscitation market boosted device acquisition activity to $4.2 billion. Twenty diagnostics financings brought in a collective $302 million, soaring above the previous quarter’s $269 million. There were seven diagnostics M&A deals completed, totaling $589 million – down yet again.
You may also be interested in...
Sientra’s “Stand-By” Series C Shows How To Eliminate Late-Stage Risk
Breast-implant start-up Sientra recently raised a $65 million Series C round at a time when venture capital for medtech is scarce, particularly for mid-stage companies pushing toward important milestones. Using a new kind of “stand-by” financing, it was ready to hit the ground running upon the recent FDA approval of its breast implants.
Covidien Acquisitions Keeps Buying Spree Alive
Since its spin-out from Tyco, Covidien has spent close to $5 billion acquiring public and privately held device companies, with more than $1 billion of that being spent just over the past six months. The string of purchases bulked up every one of Covidien’s existing medical device businesses. In the recent acquisition of superDimension, Covidien paid $300 million plus earn-outs for the maker of the iLogic system, which uses electromagnetic navigation bronchoscopy technology. The purchase means Covidien’s sales force will begin calling more on interventional pulmonologists, potentially creating an exit route for other pulmonary start-ups.
Covidien Gains Ventilators Aimed At Emerging Markets Via Newport Deal
Acquisition worth $108 million expands Covidien’s ventilator offerings, will help meet “growing customer demand in faster-growing emerging markets,” the company says.